Sipuleucel-TProvengeprostate cancermCRPCUS Food and Drug Administrationimmunotherapychemotherapieshormonal therapiesimmunotherapy-based
…nder prostate cancer a relatively immunologically “cold” tumor. Sipuleucel-T (Provenge), an autologous cellular immunotherapy, induces an im…